Recursion Pharmaceuticals
RXRX
#3231
Rank
NZ$6.31 B
Marketcap
$16.16
Share price
-10.34%
Change (1 day)
-19.26%
Change (1 year)

Market capitalization of Recursion Pharmaceuticals (RXRX)

Market cap: NZ$6.31 Billion

As of February 2025 Recursion Pharmaceuticals has a market cap of NZ$6.31 Billion. This makes Recursion Pharmaceuticals the world's 3231th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Recursion Pharmaceuticals from 2021 to 2025

2022202320242025$2B$4B$6B$8B$10Bcompaniesmarketcap.com

End of year Market Cap

Year Marketcap Change
2025NZ$6.31 B23.33%
2024NZ$5.11 B52.11%
2023NZ$3.36 B46.22%
2022NZ$2.30 B-45.69%
2021NZ$4.23 B

End of Day market cap according to different sources

On Feb 21st, 2025 the market cap of Recursion Pharmaceuticals was reported to be:

NZ$4.63 Billion
by Nasdaq info icon info icon
NZ$6.31 Billion
by CompaniesMarketCap info icon info icon